Valuation : Terumo Corporation

Market Cap 3,432B 22.26B 19.14B 18B 16.43B 30.66B 2,110B 30.82B 213B 82.52B 1,078B 83.57B 81.75B P/E 2027 *
17.3x
P/E 2028 * 17.9x
Enterprise Value 3,478B 22.55B 19.39B 18.24B 16.65B 31.07B 2,138B 31.23B 216B 83.63B 1,093B 84.69B 82.84B EV / Sales 2027 *
2.76x
EV / Sales 2028 * 2.54x
Free-Float
97.07%
Yield 2027 *
1.6%
Yield 2028 * 1.75%
1 day-2.19%
1 week-7.84%
Current month-9.56%
1 month-11.65%
3 months-0.37%
6 months+11.43%
Current year+0.24%
1 week 2,270.5
Extreme 2270.5
2,488.5
1 month 2,270.5
Extreme 2270.5
2,689
Current year 1,900
Extreme 1900
2,689
1 year 1,900
Extreme 1900
2,689
3 years 1,856
Extreme 1856
3,182
5 years 1,708
Extreme 1708
3,182
10 years 955
Extreme 955
3,182
Manager TitleAgeSince
Chief Executive Officer 62 2024-03-31
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 68 2022-03-31
Director/Board Member 63 2019-06-20
Director/Board Member 75 2020-06-24
Change 5-day change 1-year change 3-year change Capi.($)
-2.26%-7.84%-12.95%+6.23% 22.7B
-2.59%-3.13%-20.18%+4.76% 187B
-1.89%+0.38%-0.65%+15.55% 120B
-1.89%-1.90%+9.01%+82.72% 63.15B
+0.77%-3.75%+14.24%+46.18% 52.36B
-3.05%-4.29%-6.51%-32.86% 50.32B
-3.83%-6.22%+8.37%-18.99% 33.17B
-5.19%-1.20% - - 32.1B
-0.65%-0.27%+33.42%-14.09% 23.93B
-2.74%-4.88%-12.03%-1.93% 21.9B
Average -1.91%-2.21%+1.41%+9.73% 60.75B
Weighted average by Cap. -0.97%-1.52%-4.09%+13.70%

Financials

2027 *2028 *
Net sales 1,259B 8.16B 7.02B 6.6B 6.03B 11.24B 774B 11.3B 78.23B 30.27B 396B 30.65B 29.98B 1,339B 8.68B 7.47B 7.02B 6.41B 11.96B 823B 12.02B 83.22B 32.2B 421B 32.6B 31.89B
Net income 195B 1.26B 1.09B 1.02B 933M 1.74B 120B 1.75B 12.12B 4.69B 61.25B 4.75B 4.64B 192B 1.24B 1.07B 1.01B 918M 1.71B 118B 1.72B 11.92B 4.61B 60.29B 4.67B 4.57B
Net Debt 45.99B 298M 256M 241M 220M 411M 28.28B 413M 2.86B 1.11B 14.45B 1.12B 1.1B -26.39B -171M -147M -138M -126M -236M -16.23B -237M -1.64B -635M -8.29B -643M -629M
Logo Terumo Corporation
Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.
Employees
30,591
Date Price Change Volume
26-09-08 JP¥2,274.00 -2.26% 942,200
26-09-08 JP¥2,326.50 -1.98% 3,938,300
26-09-07 JP¥2,373.50 -2.41% 4,321,600
26-09-04 JP¥2,432.00 -1.44% 3,436,100
26-09-03 JP¥2,467.50 -0.06% 3,345,100
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
2,326.50JPY
Average target price
3,140.77JPY
Spread / Average Target
+35.00%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4543 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!